Related Experiment Video
Updated: May 3, 2026

Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
Activated α2-macroglobulin binding to cell surface GRP78 induces T-loop phosphorylation of Akt1 by PDK1 in
Uma Kant Misra1, Salvatore Vincent Pizzo1
1Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America.
Abstract:
PDK1 phosphorylates multiple substrates including Akt by PIP3-dependent mechanisms. In this report we provide evidence that in prostate cancer cells stimulated with activated α2-macroglobulin (α2M*) PDK1 phosphorylates Akt in the T-loop at Thr(308) by using Raptor in the mTORC1 complex as a scaffold protein. First we demonstrate that PDK1, Raptor, and mTOR co-immunoprecipitate. Silencing the expression, not only of PDK1, but also Raptor by RNAi nearly abolished Akt phosphorylation at Akt(Thr308) in Raptor-immunoprecipitates of α2M*-stimulated prostate cancer cells. Immunodepleting Raptor or PDK from cell lysates of cells treated with α2M* drastically reduced Akt phosphorylation at Thr(308), which was recovered by adding the supernatant of Raptor- or PDK1-depleted cell lysates, respectively. Studies of insulin binding to its receptor on prostate cancer cells yielded similar results. We thus demonstrate that phosphorylating the T-loop Akt residue Thr(308) by PDK1 requires Raptor of the mTORC1 complex as a platform or scaffold protein.
Insights
Phosphoinositide-dependent kinase-1 (PDK1) requires Raptor, a protein in the mTORC1 complex, to phosphorylate Akt at Thr308. This scaffolding mechanism is crucial for signaling in prostate cancer cells.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- Phosphoinositide-dependent kinase-1 (PDK1) is a key kinase involved in cell signaling pathways.
- PDK1 phosphorylates numerous substrates, including Akt, often through phosphoinositide triphosphate (PIP3)-dependent mechanisms.
- Akt phosphorylation is critical for cell growth, survival, and metabolism, and its dysregulation is implicated in cancer.
Purpose of the Study:
- To investigate the specific mechanism by which PDK1 phosphorylates Akt at the Thr308 residue in prostate cancer cells.
- To determine the role of the mTORC1 complex, specifically Raptor, in mediating PDK1-Akt interactions.
- To elucidate the signaling cascade initiated by activated α2-macroglobulin (α2M*) in prostate cancer cells.
Main Methods:
- Co-immunoprecipitation assays to detect interactions between PDK1, Raptor, and mTOR.
- RNA interference (RNAi) to silence the expression of PDK1 and Raptor.
- Immunodepletion experiments to assess the necessity of Raptor and PDK1 for Akt phosphorylation.
- Studies involving insulin receptor binding on prostate cancer cells.
Main Results:
- PDK1, Raptor, and mTOR were shown to co-immunoprecipitate, indicating their presence within the same complex.
- Silencing PDK1 or Raptor expression significantly reduced Akt phosphorylation at Thr308 in α2M*-stimulated prostate cancer cells.
- Depletion of Raptor or PDK1 from cell lysates drastically decreased Akt phosphorylation, which could be restored by adding back the depleted components.
Conclusions:
- Raptor, a component of the mTORC1 complex, acts as a scaffold protein for PDK1 to phosphorylate Akt at the Thr308 residue.
- This PDK1-Raptor scaffolding mechanism is essential for Akt activation in response to α2M* stimulation in prostate cancer cells.
- The findings reveal a novel regulatory mechanism for Akt phosphorylation, with implications for understanding prostate cancer progression and potential therapeutic targets.
More Related Videos
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
cAMP-dependent Protein Kinase Pathways
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
Receptor Tyrosine Kinases